Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Shattuck Labs, Inc.STTK · Entity 5224 | Director | July 14, 2025 | July 16, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Shattuck Labs, Inc.
Report date July 14, 2025 · Filed July 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.82 · Expires 2035-07-14 | Direct | 33,150 |
Reported balance
After 2025-07-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-07-14 · Grant · Acquired 33,150 · Balance 33,150 F1: This option represents the right to purchase a total of 33,150 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: This option represents the right to purchase a total of 33,150 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 14, 2025 Filed Jul 16, 2025 16:25 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | GrantStock Option (Right to Buy) · Derivative | 33,150 | $0.00 Strike: $0.82 | $0.00 |
DisclosureSEC source: 0000950170-25-096280 · ownership.xml · derivative · entry 1 Sasser Amy Kate · CIK 0002013454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,150 Underlying: Common Stock · 33,150 shares Expires 2035-07-14 F1 · derivative.exercise_date: This option represents the right to purchase a total of 33,150 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 21, 2024 Filed Jun 21, 2024 18:09 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | GrantStock Option (Right to Buy) · Derivative | 27,700 | $0.00 Strike: $4.37 | $0.00 |
DisclosureSEC source: 0000950170-24-076396 · ownership.xml · derivative · entry 1 Sasser Amy Kate · CIK 0002013454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,700 Underlying: Common Stock · 27,700 shares Expires 2034-06-21 F1 · derivative.exercise_date: This option represents the right to purchase a total of 27,700 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 17:31 UTC | Shattuck Labs, Inc. STTK · Entity 5224 | GrantStock Option (Right to Buy) · Derivative | 33,409 | $0.00 Strike: $9.47 | $0.00 |
DisclosureSEC source: 0000950170-24-028794 · ownership.xml · derivative · entry 1 Sasser Amy Kate · CIK 0002013454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,409 Underlying: Common Stock · 33,409 shares Expires 2034-03-06 F1 · derivative.exercise_date: This option represents the right to purchase a total of 33,409 shares of the Issuer's common stock, and vests in three equal annual installments on each of the first three anniversaries of March 1, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.